免責聲明
本網站僅提供窩客幫資訊參考平台, 並不涉入其中任何諮詢、交易。本網站對各該窩客幫相關資訊亦不作任何實質或形式上之審查。本網站中所載一切窩客幫的資訊、文字、照片、圖形 、產權、廣告內容、或其他資料(以下簡稱『內容』)。無論其為公開張貼或私下傳送,若有不實或違法情事,均為『內容』提供者之責任,窩客幫概不負責也不承擔任何法律責任。
Glac Biotech Co., Ltd. – Probiotics, Probiotic Supplements, Probiotic Manufacturer, Probiotic Nutrit
文章管理
B. animalis subsp. lactis CP-9

Premium Probiotic Ingredient from Healthy Human Breast Milk

Bifidobacteria are key early colonizers of the human gut microbiota. CP-9, isolated from healthy human breast milk, is produced under our PRONEX® quality platform to ensure outstanding stability and performance. The strain has been evaluated across in-vitro, animal, and human studies, providing scientific support for roles in gut microbiota balance, metabolic health, immune balance, and skin wellness.


 
 


Core Advantages

Our value is to deliver safe, high-quality, and multifunctional probiotic ingredients.
  • International safety framework: At the species level, B. animalis subsp. lactis is included on the EFSA QPS (Qualified Presumption of Safety) list. CP-9 is recognized for food use in select APAC markets, including Taiwan and Mainland China. A comprehensive CP-9 safety assessment was published in Journal of Food Science (2022), indicating no toxicity, no mutagenicity risk, and safety under prolonged intake.
  • Robust scientific evidence: CP-9 is supported by 14+ patents (US/CN/TW) and 19+ SCI-indexed publications and academic reports. In 2023, CP-9 was a NutraIngredients Weight Management category finalist.


Advanced Quality & Identification (PRONEX®)

Our proprietary PRONEX® platform conducts full identity confirmation, purity verification, and functional characterization of CP-9. This technology underpins our quality commitment and ensures batch-to-batch consistency to the highest standards.


Excellent Stability & Application Potential

CP-9 shows strong acid and bile salt tolerance and intestinal adhesion, helping it transit the digestive tract and perform as intended. With appropriate packaging and storage, room-temperature shelf life is up to 36 months, facilitating versatile product development.


Research Areas & Applications

The multifunctionality of CP-9 makes it an ideal choice for diverse formulations.
  • Gut health: Supports a balanced gut microbiota and digestive comfort.
  • Metabolic health & weight management: Studies report associations with favorable trends in body composition as well as glycemic and lipid markers.
  • Immune balance & antioxidation: In-vitro data indicate links to IL-10–related anti-inflammatory signaling and antioxidant capacity, supporting immune balance.
  • Skin wellness: Supports comfort in sensitive skin and barrier function.
  • Liquid-format patent application: Protected formulation (e.g., TWI800860) suitable for infants and adults preferring liquids; easy to incorporate into various foods.


Multi-strain Formulation Use

CP-9 can be combined with other strains to deliver comprehensive solutions, for example:
NosRelieve
respiratory wellness support
FitStay
weight management concepts
GlukoSolu
glycemic/metabolic support
IntBrain
cognitive & mood support



Key Patent List

  • TWI800740 – Composition for supporting bowel movements
  • TWI572713 – Anti-obesity/weight-management applications
  • TWI777475 – Support for glycemic metabolism
  • TWI797881 – Healthy aging–related applications
  • TWI786343 – Skin tone/brightening–related applications
  • TWI777107 – Antioxidant-related applications
  • TWI759126 – Anti-inflammatory–related applications
  • TWI809634, TWI750716 – Skin comfort and inflammatory response–related applications
  • TWI819926, TWI790820 – Pediatric care–related applications


📧 Contact us: glac@glac.com.tw

Further Reading:
  1. Glac Single Strain Probiotic Powder - Live Probiotic Powder
  2. PRONULIFE® Functional Probiotic Ingredients

 

References

  1. Bacteriostatic activities of lactic acid bacteria against extended-spectrum β-lactamase(ESBL)-producing Escherichia coli. Basic Clin Pharmacol Toxicol. 2019;125(Suppl. 6):3-4.
  2. Bacteriostatic abilities of viable and heat-killed lactic acid bacteria against group B Streptococcus. Basic Clin Pharmacol Toxicol. 2019;125(Suppl. 6):12-13.
  3. Assessment of bacteriostatic activities of viable and non-viable lactic acid bacteria against methicillin-resistant Staphylococcus aureus. Basic Clin Pharmacol Toxicol. 2019;125(Suppl. 6):14-15.
  4. Antibacterial activity of viable and heat-killed
    probiotic strains against oral pathogens. Lett Appl Microbiol. 2020 Apr;70(4):310-317.


 
相關文章
Glac Biotech Co., Ltd. – Probiotics, Probiotic Supplements, Probiotic Manufacturer, Probiotic Nutrit
電話 : +886-6-589-1876 地址 : 1 F., No. 139, Sanmin St., Xinshi Dist., Tainan City 744007, Taiwan (R.O.C.)

  • 服務項目

  • 特別關鍵字

    probiotics, probiotic supplements, probiotics recommendation, probiotic nutritional products, probiotic factory, probiotic manufacturer, probiotic export, probiotic contract manufacturing, probiotic ODM, probiotic CDMO, customized probiotics, dietary supplement ODM, dietary supplement OEM, postbiotics ODM, postbiotics OEM, postbiotic supplements, sleep support probiotics, sports probiotics, uric acid probiotics, allergy relief probiotics, gastrointestinal health, gastrointestinal probiotics, women’s intimate probiotics, breast milk probiotics, health probiotics, immune-boosting probiotics